Alfacell About
Alfacell Alfacell is a biopharmaceutical company focused
on the discovery, development and commercialization of novel ribonucleases (RNases).
Their mission is to develop new therapeutics from their novel ribonuclease technology
platform for the treatment of cancer, infectious diseases and other life threatening
conditions, thus offering new horizons of hope for patients and physicians. Onconase
(ranpirnase) --a Ribonuclease anti-cancer drug Oncanase data: Animal
studies have shown that using ONCONASE alone effectively kills cancer cells with
manageable toxicity. ONCONASE improves radiation response and enhances the efficacy
of commonly used chemotherapeutic agents (such as cisplatin and carboplatin) in
human NSCLC xenografts of nude mice.
More on Alfacell: